Literature DB >> 987041

Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients.

D A Cooley, D C Wukasch, R D Leachman.   

Abstract

Treatment of idiopathic hypertrophic subaortic stenosis (IHSS) remains a controversial problem and depending upon many factors, medical or surgical treatment may be elected. When medical therapy fails and surgery is recommended, choice of an appropriate surgical technique may be difficult. An analysis is given of 27 patients who have undergone only mitral valve replacement as definitive treatment. Twenty-six patients were dismissed from the hospital with good or excellent results and one died (3.7 percent mortality). Pressure gradients across the left ventricular outflow tract after operation were eliminated in every instance. The mean preoperative gradient was 74 mm Hg and postoperatively was 6.9 mm Hg. Advantages and disadvantages of mitral valve replacement as definitive treatment of IHSS are presented. This method of treatment should be reserved for patients with incapacitating symptoms, congestive heart failure, severe left ventricular hypertension, unusual electrocardiographic findings or in patients who have failed to respond favorably to previous septectomy.

Entities:  

Mesh:

Year:  1976        PMID: 987041

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  10 in total

1.  Long-term results of apico-aortic valved conduit for severe idiopathic hypertrophic subaortic stenosis.

Authors:  A Renzulli; R Gregorio; M De Feo; G Ismeno; F E Covino; M Cotrufo
Journal:  Tex Heart Inst J       Date:  2000

2.  Pacing for hypertrophic obstructive cardiomyopathy does it work?

Authors:  Q Zaidi; H Zaky; O Aljassim
Journal:  J Saudi Heart Assoc       Date:  2009-08-05

3.  [Mitral valve replacement for three cases of hypertrophic obstructive cardiomyopathy--surgical treatment].

Authors:  Y Koh; T Okubo; R Hoshino; Y Kamigaki; S Ouchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

4.  Surgery for hypertrophic cardiomyopathy.

Authors:  James J Wu; Michael Seco; Caroline Medi; Chris Semsarian; David R Richmond; Joseph A Dearani; Hartzell V Schaff; Michael J Byrom; Paul G Bannon
Journal:  Biophys Rev       Date:  2015-01-10

Review 5.  Nonobstructive and obstructive hypertrophic cardiomyopathies.

Authors:  J Ross; R Shabetai; G Curtis; R L Engler; D L Costello; M M LeWinter; A D Johnson; C B Higgins; G Gregoratos; J R Utley; R Shabetai
Journal:  West J Med       Date:  1979-04

6.  Mitral valve replacement using a porcine xenograft for treatment of IHSS--A case report.

Authors:  H Nagara; H Tamura; M Atobe; M Matsumoto; H Hiratsuka
Journal:  Jpn J Surg       Date:  1978-12

7.  Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its time come?

Authors:  R A Nishimura; G K Danielson
Journal:  Br Heart J       Date:  1993-10

8.  In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction.

Authors:  Dae-Hee Kim; Mark D Handschumacher; Robert A Levine; Yun-Sil Choi; Yun Jeong Kim; Sung-Cheol Yun; Jong-Min Song; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Circulation       Date:  2010-09-13       Impact factor: 29.690

9.  DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.

Authors:  A K Slade; N Sadoul; L Shapiro; L Chojnowska; J P Simon; R C Saumarez; B Dodinot; A J Camm; W J McKenna; E Aliot
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

10.  Pattern and degree of left ventricular remodeling following a tailored surgical approach for hypertrophic obstructive cardiomyopathy.

Authors:  Ismail El-Hamamsy; Karim Lekadir; Iacopo Olivotto; Ahmed El Guindy; Robert Merrifield; Luigi Rega; GuangZong Yang; Franco Cecchi; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2012-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.